Paclitaxel Polymeric Micelles and Carboplatin in Combination With Iparomilimab and Tuvonralimab Neoadjuvant Therapy for Triple-negative Breast Cancer（UPGRADE-TNBC）

Clinical trial NCT06910072 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT06910072
Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status: ENROLLING_BY_INVITATION
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Triple-Negative Breast Cancer (TNBC)Neoadjuvant Therapy

Start date: 2025-07-21
Primary completion: 2027-06-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.